Skip to content
HowShorted

ABEONA THERAPEUTICS INC. short interest in 2023

In 2023, ABEONA THERAPEUTICS INC.'s disclosed short interest ran from 4.25% of shares outstanding on 13 Jan 2023 to 2.44% on 29 Dec 2023, a change of -1.81 percentage points. The year's high was 4.25% on 13 Jan 2023 and its low 1.73% on 15 Dec 2023, averaging 2.77% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.86 days on 14 Apr 2023. Full history: ABEONA THERAPEUTICS INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for ABEONA THERAPEUTICS INC. in 2023

2023 in figures

Start of year
4.25% (13 Jan 2023)
End of year
2.44% (29 Dec 2023)
Change
-1.81 pp
High
4.25% (13 Jan 2023)
Low
1.73% (15 Dec 2023)
Average
2.77%
Highest days to cover
8.86 (14 Apr 2023)
SEC filings marked
8

Every report in 2023

ABEONA THERAPEUTICS INC. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20234.25%2.12
31 Jan 20233.05%3.04
15 Feb 20232.51%2.95
28 Feb 20232.68%3.68
15 Mar 20233.52%2.40
31 Mar 20234.24%5.3610-K filed, results (8-K)
14 Apr 20233.39%8.86
28 Apr 20232.89%3.07
15 May 20232.07%4.0510-Q filed, results (8-K)
31 May 20232.45%3.97
15 Jun 20232.66%1.60
30 Jun 20233.03%2.67
14 Jul 20234.19%3.67
31 Jul 20233.04%3.27
15 Aug 20231.79%5.1610-Q filed, results (8-K)
31 Aug 20232.02%3.61
15 Sep 20232.43%6.04
29 Sep 20232.50%3.65
13 Oct 20232.50%4.83
31 Oct 20232.55%8.54
15 Nov 20232.44%6.8310-Q filed, results (8-K)
30 Nov 20232.22%1.97
15 Dec 20231.73%2.54
29 Dec 20232.44%2.06

See also: ABEONA THERAPEUTICS INC.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.